Great Lakes Advisors LLC Increases Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Great Lakes Advisors LLC raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.9% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 227,907 shares of the company’s stock after buying an additional 6,477 shares during the period. Great Lakes Advisors LLC’s holdings in GE HealthCare Technologies were worth $17,818,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Ashton Thomas Securities LLC purchased a new stake in GE HealthCare Technologies during the 3rd quarter valued at $26,000. Darwin Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth about $31,000. Continuum Advisory LLC lifted its position in shares of GE HealthCare Technologies by 101.8% in the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after purchasing an additional 168 shares during the period. Bank of Jackson Hole Trust purchased a new stake in shares of GE HealthCare Technologies in the 4th quarter worth about $32,000. Finally, OFI Invest Asset Management purchased a new stake in shares of GE HealthCare Technologies in the 4th quarter worth about $34,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on GEHC shares. Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Citigroup raised their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Finally, The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and increased their price target for the stock from $85.00 to $100.00 in a research note on Tuesday. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $98.75.

GE HealthCare Technologies Stock Down 2.1 %

NASDAQ:GEHC opened at $83.79 on Thursday. The firm has a market cap of $38.32 billion, a P/E ratio of 19.35, a P/E/G ratio of 3.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The firm has a 50-day simple moving average of $87.17 and a two-hundred day simple moving average of $86.16.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. Analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.